Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial

Autor:	Masataka Tanimoto, Kazuaki Enya, Kentarou Kudou, Yutaka Osuga, Hiroshi Hoshiai
Rok vydání:	2019
Předmět:	medicine.medical_specialty medicine.drug_class Urology Gonadotropin-releasing hormone antagonist law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Leuprorelin law Severity of illness medicine 030212 general & internal medicine neoplasms 030219 obstetrics & reproductive medicine Uterine leiomyoma business.industry Obstetrics and Gynecology General Medicine female genital diseases and pregnancy complications surgical procedures operative Menstrual bleeding Multicenter study In utero business medicine.drug
Zdroj:	Obstetrical & Gynecological Survey. 74:406-407
ISSN:	1533-9866 0029-7828
DOI:	10.1097/01.ogx.0000568888.86662.e0
Popis:	OBJECTIVE:To investigate the noninferiority of relugolix compared with leuprorelin acetate in reducing heavy menstrual bleeding associated with uterine leiomyomas.METHODS:In a double-blind, double-dummy trial, premenopausal women with uterine leiomyomas and heavy menstrual bleeding defined as a pict
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a315e4ab178196b706f686e8c6756a https://doi.org/10.1097/01.ogx.0000568888.86662.e0 Zobrazit plný text záznamu